undefined

undefined

Home page

Jiudian Pharmaceutical's Dapagliflozin Tablets Approved for Marketing

Jiudian Pharmaceutical's Dapagliflozin Tablets Approved for Marketing

At the beginning of 2025, after review by the Drug Evaluation Center of the NMPA, Jiudian Pharmaceutical's dapagliflozin tablets were approved for marketing. Jiudian® dapagliflozin tablets had successfully broken through the patent barriers of the original crystal form before they were launched, and passed the consistency evaluation, ensuring the safety and effectiveness of the drug, which can reduce the medication burden for diabetic patients and improve the accessibility of diabetic patients.

06

2025

/

01

Jiudian Production Center held a symposium for new employees

Jiudian Production Center held a symposium for new employees

On Dec 26, a well-organized symposium for new employees was held as scheduled at Jiudian Production Center. Director Xiang, Deputy Director Lu, Deputy Director of the Administration Department Liu, Deputy Director of the Human Resources Department Wang and others attended the meeting and talked about future development with 50 new employee representatives.

27

2024

/

12

Jiudian Pharmaceutical Research Institute organizes training on preparation microscopic analysis technology

Jiudian Pharmaceutical Research Institute organizes training on preparation microscopic analysis technology

Recently, Jiudian Pharmaceutical Research Institute invited Mr. Liu from Zhejiang Jieheng Technology to hold a training on preparation microscopic analysis technology in the company's headquarters 622 conference room. The deputy director of Jiudian Pharmaceutical Research Institute and director of the Second Institute of Oral Solid Preparations, deputy director of the First Institute of Oral Preparations, and heads and researchers of relevant departments such as oral solid preparations and topical preparations attended the meeting.

27

2024

/

12

Jiudian Production Center carries out mechanical injury prevention training

Jiudian Production Center carries out mechanical injury prevention training

In order to enhance employees' safety awareness and effectively prevent the occurrence of mechanical injury accidents, from December 10 to 18, Jiudian Production Center organized 231 front-line employees involved in mechanical operation positions to carry out mechanical injury prevention training in four sessions in the north and south training rooms.

20

2024

/

12

Jiudian Hongyang's API Dapagliflozin is approved for marketing

Jiudian Hongyang's API Dapagliflozin is approved for marketing

Jiudian Hongyang's API dapagliflozin (Y20230000318) officially obtained the marketing approval from the CDE, and its registration status was successfully transferred to "A".

17

2024

/

12

Dianyukang Pharmaceuticals attended the 89th PHARMCHINA

Dianyukang Pharmaceuticals attended the 89th PHARMCHINA

On November 20, the 89th PHARMCHINA kicked off at the Wuhan International Expo Center. Dianyukang Pharmaceutical Executive Director Zhu Jiawen and General Manager Zheng Liang led a team and made a shining appearance at the conference with their high-quality products.

26

2024

/

11

Jiudian Hongyang passed the on-site registration inspection of API Lacidipine and the GMP compliance inspection of 5 varieties including oseltamivir phosphate

Jiudian Hongyang passed the on-site registration inspection of API Lacidipine and the GMP compliance inspection of 5 varieties including oseltamivir phosphate

Recently, Jiudian Hongyang passed the on-site verification of the registration of API lacidipine and the GMP compliance inspection of 5 varieties including oseltamivir phosphate.

13

2024

/

11

Jiudian Pharmaceutical once again ranked on the two most influential lists in the pharmaceutical industry

Jiudian Pharmaceutical once again ranked on the two most influential lists in the pharmaceutical industry

From November 4th to 6th, the 3rd Taishan Pharmaceutical Forum and the 2023-2024 Pharmaceutical Industry Information Release Conference were held in Jinan, Shandong. With its good operating performance and strong innovation capabilities, Jiudian Pharmaceuticalwas listed in the "Top 100 Companies in Pharmaceutical Industry Revenue" and "Top 50 Companies in Pharmaceutical Industry Growth Rate" in 2023-2024.

11

2024

/

11

< 1...11 12 13...17 >

Hunan Jiudian

Bldg A1, Wukuang Lugu Science and Technology Industry Park, No.28 Lutian Road, Hi-tech development zone, Changsha, Hunan, China TEL. 0086-731-88220222

1

Business license

Powered by：CEglobal Privacy policy